Phase 1 Heart Failure Clinical Trials
28 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–20 of 28 trials
Recruiting
Phase 1
Autologous Induced Pluripotent Stem Cells of Cardiac Lineage for Congenital Heart Disease
Congenital Heart DiseaseHeart Failure NYHA Class IIIHeart Failure NYHA Class IV+1 more
HeartWorks, Inc.50 enrolled1 locationNCT05647213
Recruiting
Phase 1Phase 2
Treating Heart Dysfunction Related to Cancer Therapy With Sacubitril/Valsartan
Heart FailureHeart Dysfunction
Virginia Commonwealth University53 enrolled1 locationNCT05194111
Recruiting
Phase 1
Vericiguat in Decompensated Cardiac Failure: Clinical Insights on Addition to Guidelines Derived Medical Therapy-VERCIG Trial
Decompensated Heart Failure
Khawaja Danish Ali130 enrolled1 locationNCT07444398
Recruiting
Phase 1
A Safety, Tolerability, and Biomarker Trial of VS-041 in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)
Heart Failure With Preserved Ejection Fraction (HFpEF)Heart
Vasa Therapeutics42 enrolled17 locationsNCT07219511
Recruiting
Phase 1Phase 2
Safety and Efficacy of Induced Pluripotent Stem Cell-derived Engineered Human Myocardium as Biological Ventricular Assist Tissue in Terminal Heart Failure
Heart Failure
University Medical Center Goettingen53 enrolled3 locationsNCT04396899
Recruiting
Phase 1Phase 2
A Phase I/II Clinical Trial of Intramyocardial Injection of HucMSCs for the Treatment of Chronic Heart Failure
Chronic Heart FailureCoronary Artery Bypass Grafting (CABG)Chronic Ischemic Cardiomyopathy
Tasly Pharmaceutical Group Co., Ltd51 enrolled4 locationsNCT07265349
Recruiting
Phase 1
Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines
Heart FailureMalignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+1 more
M.D. Anderson Cancer Center72 enrolled1 locationNCT02962661
Recruiting
Phase 1
A Research Study on the Effects of NNC0537-1482 in Participants With Heart Failure
Heart Failure
Novo Nordisk A/S36 enrolled1 locationNCT07218627
Recruiting
Phase 1
The Effects of IL-1 Blockade on Inotrope Sensitivity in Patients With Heart Failure (AID-HEART)
Heart Failure
Virginia Commonwealth University20 enrolled1 locationNCT06062966
Recruiting
Phase 1
: Vascular Function in Health and Disease
Heart FailureHypertensionChronic Obstructive Pulmonary Disease+1 more
Russell Richardson420 enrolled1 locationNCT02966665
Recruiting
Phase 1Phase 2
Effect of Dapagliflozin on Metabolomics and Cardiac Mechanics in Chronic Kidney Disease
Heart FailureChronic Kidney DiseasesKidney Diseases+1 more
Northwestern University60 enrolled1 locationNCT05719714
Recruiting
Phase 1Phase 2
Empagliflozin in ESKD - A Feasibility Study
Heart FailureKidney Failure, Chronic
University of Mississippi Medical Center24 enrolled2 locationsNCT05687058
Recruiting
Phase 1
Novel Approaches for Improving Vascular Function in Veterans With HFpEF
InflammationHeart Failure With Preserved Ejection Fraction
VA Office of Research and Development90 enrolled1 locationNCT06312748
Recruiting
Phase 1
Mechanisms of Diuretic Resistance in Heart Failure, Aim 2
Heart Failure
Yale University50 enrolled1 locationNCT05753059
Recruiting
Phase 1Phase 2
Peritoneal Ultrafiltration in Cardio Renal Syndrome.
Congestive Heart Failure
Iperboreal Pharma Srl84 enrolled3 locationsNCT03994874
Recruiting
Phase 1
Study Assessing Left Ventricular Administration of a Genetic Medicine Directing Organ Regeneration in Heart Failure
Heart Failure With Reduced Ejection Fraction
YAP Therapeutics, Inc.24 enrolled1 locationNCT06831825
Recruiting
Phase 1Phase 2
Colchicine in Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction
HFpEF - Heart Failure With Preserved Ejection FractionColchicine
I.M. Sechenov First Moscow State Medical University40 enrolled2 locationsNCT05637398
Recruiting
Phase 1
Study in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)
Heart Failure With Preserved Ejection Fraction (HFpEF)
Secretome Therapeutics12 enrolled2 locationsNCT06560762
Recruiting
Phase 1
Mechanisms of Diuretic Resistance in Heart Failure, Aim 1
Heart Failure
Yale University75 enrolled1 locationNCT05323487
Recruiting
Phase 1
Effects of Acute and Chronic Empagliflozin Heart Failure
Heart Failure
Yale University60 enrolled2 locationsNCT05553938